ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.002,02
-1,43%
S&P 500
5.431,60
-0,04%
Dow Jones
38.589,16
-0,15%
Euro vs US Dollar
1,07175
-0,05%
Bitcoin
66.048,55
0,07%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Roquefort Therapeutics Plc (ROQ)

  7. Roquefort Therapeutics Plc (ROQ) News

ROQ

Roquefort Therapeutics (ROQ)

Roquefort Therapeutics Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:ROQ
DatumZeitQuelleÜberschriftSymbolFirma
04/06/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Notice of Annual General MeetingLSE:ROQRoquefort Therapeutics Plc
23/05/202422h25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202422h25Alliance NewsAlliance NewsTRADING UPDATES: Windward wins deal; Kodal progresses at BougouniLSE:ROQRoquefort Therapeutics Plc
23/05/202408h05RNS Regulatory NewsRoquefort Therapeutics PLC Issue of Convertible Loan Notes & Board ChangesLSE:ROQRoquefort Therapeutics Plc
23/05/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Midkine Antibody Licencing DealLSE:ROQRoquefort Therapeutics Plc
26/04/202421h59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202421h59Alliance NewsAlliance NewsEARNINGS AND TRADING: Aura confident in Tiris; Cindrigo enters GermanyLSE:ROQRoquefort Therapeutics Plc
26/04/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Annual Report & Financial Statements - 31 Dec 2023LSE:ROQRoquefort Therapeutics Plc
05/04/202413h32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202413h32Alliance NewsAlliance NewsIN BRIEF: Roquefort cancels fundraise after "unusual" stock movementsLSE:ROQRoquefort Therapeutics Plc
05/04/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Response to Share Price MovementLSE:ROQRoquefort Therapeutics Plc
11/03/202412h12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202412h12Alliance NewsAlliance NewsRoquefort celebrates "significant milestones" in cancer researchLSE:ROQRoquefort Therapeutics Plc
11/03/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Positive Results: Midkine mRNA and STAT-6 siRNALSE:ROQRoquefort Therapeutics Plc
06/02/202417h50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202417h50Alliance NewsAlliance NewsIN BRIEF: Roquefort hails further MK studies, licence talks continueLSE:ROQRoquefort Therapeutics Plc
06/02/202408h00RNS Regulatory NewsRoquefort Therapeutics PLC Operations UpdateLSE:ROQRoquefort Therapeutics Plc
24/11/202308h00UK RegulatoryRoquefort Therapeutics PLC Change of AuditorLSE:ROQRoquefort Therapeutics Plc
06/11/202313h01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202313h01Alliance NewsAlliance NewsRoquefort Therapeutics MK cell programme shows positive resultsLSE:ROQRoquefort Therapeutics Plc
06/11/202308h00UK RegulatoryRoquefort Therapeutics PLC Significant Mesodermal Killer Cell MilestoneLSE:ROQRoquefort Therapeutics Plc
27/09/202316h43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202316h43Alliance NewsAlliance NewsEARNINGS: Biome loss widens; Amicorp focused on growth post-IPOLSE:ROQRoquefort Therapeutics Plc
27/09/202308h00UK RegulatoryRoquefort Therapeutics PLC Interim Results to 30 June 2023LSE:ROQRoquefort Therapeutics Plc
22/09/202312h42RNS Non-RegulatoryRoquefort Therapeutics PLC Investor Presentation via Investor Meet CompanyLSE:ROQRoquefort Therapeutics Plc
14/08/202312h07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202312h07Alliance NewsAlliance NewsRoquefort files patent application for mRNA and RNA therapiesLSE:ROQRoquefort Therapeutics Plc
14/08/202308h00UK RegulatoryRoquefort Therapeutics PLC Expansion of Patent PortfolioLSE:ROQRoquefort Therapeutics Plc
07/08/202312h04Alliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
07/08/202312h04Alliance NewsAlliance NewsIN BRIEF: Roquefort announces new sirNA sequences and patent filingLSE:ROQRoquefort Therapeutics Plc
 Showing the most relevant articles for your search:LSE:ROQ

Kürzlich von Ihnen besucht

TG
BAYN
Bayer
NYSE
MCD
McDonalds
TG
MBG
MercedesBenz
USOTC
ADDYY
Adidas (QX)
COIN
BTCUSD
Bitcoin
CCOM
US500
US 500
FX
EURUSD
Euro vs US Dollar
NASDAQ
GOOGL
Alphabet
PM
XAUUSD
Gold vs US Dollar
AMEX
XLF
Financial Select Sector
AMEX
SPY
SPDR S&P 500
TG
DBK
Deutsche Bank
NYSE
KO
Coca Cola
NYSE
NKE
Nike
TG
432
Arbor Metals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten